Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CITIUS ONCOLOGY, INC.CTOR · Entity 6935 | Director | September 19, 2025 | December 22, 2025 |
| Citius Pharmaceuticals, Inc.CTXR · Entity 7778 | Director | November 07, 2024 | November 12, 2024 |
| DarioHealth Corp.DRIO · Entity 7024 | Director | September 24, 2026 | September 28, 2026 |
| FC Global Realty IncFCRE · Entity 169560 | Director | December 22, 2017 | December 28, 2017 |
| Lucid Diagnostics Inc.LUCD · Entity 6375 | Chief Financial Officer | February 20, 2026 | February 24, 2026 |
| PAVmed Inc.PAVM · Entity 7317 | President and CFO | April 02, 2026 | April 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CITIUS ONCOLOGY, INC.
Report date September 19, 2025 · Filed December 22, 2025 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 300,000 |
Reported balance
After 2025-09-19 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2025-09-19 · Grant · Acquired 300,000 · Balance 300,000 F1: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
Citius Pharmaceuticals, Inc.
Report date November 07, 2024 · Filed November 12, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Purchase Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $0.38 · Expires 2034-11-07 | Direct | 125,000 |
Reported balance
After 2024-11-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-11-07 · Grant · Acquired 125,000 · Balance 125,000 F1: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date. |
| Stock Option (Right to Purchase Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $0.70 · Expires 2033-10-10 | Direct | 75,000 |
Reported balance
Holding disclosure · report date 2024-11-07 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 75,000 F2: The options are vested in full and exercisable immediately. |
| Stock Option (Right to Purchase Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $1.42 · Expires 2033-02-07 | Direct | 75,000 |
Reported balance
Holding disclosure · report date 2024-11-07 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 75,000 F2: The options are vested in full and exercisable immediately. |
Filing footnotes · ownership attribution and instrument terms
F1: The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
F2: The options are vested in full and exercisable immediately.
DarioHealth Corp.
Report date September 24, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 88,737 |
Reported balance
After 2026-09-24 transaction · row 1
1 source rowRow 1 · 2026-09-24 · Grant · Acquired 61,000 · Balance 88,737 F1: The restricted share award shall vest on the second anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted share award shall vest on the second anniversary of the grant date.
FC Global Realty Inc
Report date December 22, 2017 · Filed December 28, 2017 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| FC Global Common StockSEC Table I · non-derivative | Direct | 1,029,238 |
Reported balance
After 2017-12-22 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2017-12-22 · Other · Acquired 977,960 · Balance 1,029,238 F1: The transactions reported on this Form 4 were effected pursuant to a Convertible Payout Note dated May 17, 2017 and the Stock Grant Agreement dated December 22, 2017. F2: The price reported in Column 4 was set by the terms of the Convertible Payout Note dated May 17, 2017 and the Stock Grant Agreement dated December 22, 2017. F3: The total shares reflected in Column 5 includes the shares granted under the Convertible Payout Note dated May 17, 2017 and the Stock Grant Agreement dated December 22, 2017 as well as the shares previously held by Mr. McGrath after adjustment for a 1-for-5 reverse stock split in September 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported on this Form 4 were effected pursuant to a Convertible Payout Note dated May 17, 2017 and the Stock Grant Agreement dated December 22, 2017.
F2: The price reported in Column 4 was set by the terms of the Convertible Payout Note dated May 17, 2017 and the Stock Grant Agreement dated December 22, 2017.
F3: The total shares reflected in Column 5 includes the shares granted under the Convertible Payout Note dated May 17, 2017 and the Stock Grant Agreement dated December 22, 2017 as well as the shares previously held by Mr. McGrath after adjustment for a 1-for-5 reverse stock split in September 2016.
Lucid Diagnostics Inc.
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 1,813,569 |
Reported balance
After 2026-02-20 transaction · row 1
1 source rowRow 1 · 2026-02-20 · Grant · Acquired 470,000 · Balance 1,813,569 F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
PAVmed Inc.
Report date April 02, 2026 · Filed April 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 186,695 |
Reported balance
After 2026-04-02 transaction · row 1
1 source rowRow 1 · 2026-04-02 · Grant · Acquired 180,000 · Balance 186,695 F1: Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 24, 2017 Filed Aug 28, 2017 11:14 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 1,000 | $4.24 | $4,242.90 |
DisclosureSEC source: 0001094891-17-000223 · edgar.xml · nonDerivative · entry 5 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 12,000 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 11:14 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.24 | $2,121.00 |
DisclosureSEC source: 0001094891-17-000223 · edgar.xml · nonDerivative · entry 4 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 11,000 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 11:14 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.24 | $2,119.95 |
DisclosureSEC source: 0001094891-17-000223 · edgar.xml · nonDerivative · entry 3 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 10,500 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 11:14 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.19 | $2,094.00 |
DisclosureSEC source: 0001094891-17-000223 · edgar.xml · nonDerivative · entry 2 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 10,000 Read SEC document |
| August 24, 2017 Filed Aug 28, 2017 11:14 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.17 | $2,087.15 |
DisclosureSEC source: 0001094891-17-000223 · edgar.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 9,500 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.18 | $2,089.40 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 6 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 9,000 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.17 | $2,085.00 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 5 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 8,500 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.15 | $2,074.80 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 4 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 8,000 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.12 | $2,061.70 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 3 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 7,500 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.12 | $2,059.20 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 2 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 7,000 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 11:05 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $3.90 | $1,952.00 |
DisclosureSEC source: 0001094891-17-000217 · edgar.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 6,500 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.25 | $2,124.95 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 11 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 6,000 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.24 | $2,120.95 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 10 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 5,500 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.24 | $2,120.90 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 9 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 5,000 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.24 | $2,117.50 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 8 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 4,500 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.15 | $2,073.70 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 7 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 4,000 Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.12 | $2,061.65 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 6 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 3,500 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.24 | $2,120.85 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 5 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 3,000 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 1,000 | $4.24 | $4,241.40 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 4 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 2,500 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.22 | $2,112.45 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 3 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 1,500 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.22 | $2,108.90 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 2 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 1,000 Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 11:22 UTC | PAVmed Inc. PAVM · Entity 7317 | PurchaseCommon Stock | 500 | $4.09 | $2,046.05 |
DisclosureSEC source: 0001094891-17-000215 · edgar.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · By MSSB C/F Dennis M. McGrath IRA Disclosed balance after: 500 Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 20:04 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 4,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-036434 · v470574_4.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,627 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2017 in the amount of $10,250. Read SEC document |
| April 13, 2017 Filed Apr 17, 2017 20:23 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 2,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-020719 · v464369_4.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,194 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2017 in the amount of $10,250. Read SEC document |
| March 20, 2017 Filed Mar 21, 2017 20:27 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001094891-17-000081 · edgar.xml · derivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2027-03-19 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments on the last day of each fiscal quarter, commencing on June 30, 2017. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 21:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 16,007 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001144204-17-005352 · v457876_4.xml · derivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,007 Underlying: Common Stock · 16,007 shares Expires 2023-01-30 F1 · derivative.exercise_date: The option vests in twelve equal quarterly installments commencing on January 30, 2017. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 21:40 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 6,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-002211 · v456900_4.xml · nonDerivative · entry 1 MCGRATH DENNIS M · CIK 0001269340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,394 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter and fourth quarter of 2016 in the amount of $20,500. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.